USA Pamela Gavin, CEO of the National Organization for Rare Disorders, discusses NORD’s origins in the advocacy movement that led to the Orphan Drug Act and its current mission to improve diagnosis, care, research, and policy for rare disease patients. She highlights the growing role of patient-led research, the need for…
Europe Europe’s place in the global biotechnology race is entering a decisive phase. Scientific excellence and industrial depth remain powerful advantages, yet intensifying competition from the United States and China is exposing the need for faster execution, stronger capital markets, and a more coherent single market. Claire Skentelbery outlines why biotechnology…
Germany Germany and Europe have every reason to remain optimistic, provided we build on the strengths we already have As Europe seeks to strengthen its pharmaceutical resilience and Germany redefines its healthcare and industrial priorities, the decisions taken today will shape the sector’s competitiveness for decades to come. Dr Kai Joachimsen,…
Korea Korea has something that very few countries can claim: high-quality healthcare data at genuine population scale JK Lee, Vice President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), outlines Korea’s transition from a generics-driven industry to a global innovation hub. He highlights the government’s strategic support, a growing pipeline…
Korea If you concentrate on shared goals, collaboration and a unified voice follow naturally. Youngshin Lee, CEO of KRPIA, has built a career spanning more than three decades across pharmaceutical R&D, industry, and policy, advocating for collaboration between regulators, industry, and patients. Under her leadership, KRPIA has become a key voice…
Korea As the world around us changes, we need to change with it Marie Antonia von Schönburg has been President and Chief Executive of the Korean-German Chamber of Commerce and Industry in Seoul for 16 months. With 26 years of experience across the global network of German Chambers abroad,…
Japan Hideyasu Matsuda and Toru Fujieda of the Japan CRO Association argue that, thanks to an updated regulatory framework, Japan is becoming one of the most competitive and operationally attractive clinical development destinations in the world. Japan is an attractive clinical trial destination from a cost, quality, and speed perspective…
Korea Jurie Hwang is the Director of Public & International Affairs of KoreaBIO, the largest and most broadly constituted life sciences industry association in South Korea. With 650 member organisations spanning the entire value chain of the bio economy – from early-stage start-ups and venture capital firms to major conglomerates and…
Korea Dr Jeongseok Lee has served as President of the Korea Biomedicine Industry Association (KoBIA) since September 2020, backed by an outstanding 35-year career in public service and longstanding leadership in the healthcare sector. During a period marked by the unprecedented public health crisis of the COVID-19 pandemic and the significant…
Europe For years, Europe’s pharmaceutical sector has warned about declining competitiveness. Today, according to Nathalie Moll, Director General of EFPIA, that concern has evolved into something far more urgent. As the US and China accelerate their industrial and innovation strategies, Europe finds itself at a critical crossroads where decisions around regulation,…
Germany Germany’s biotechnology sector finds itself at a critical inflection point as political ambition, scientific strength, and industrial policy begin to converge around a shared objective: positioning the country as a leading global biotechnology hub. Yet behind the momentum lies a more complex reality, shaped by financing constraints, regulatory fragmentation, scale-up…
Germany Germany’s research-based pharmaceutical industry is approaching a defining period as mounting pressure to curb healthcare expenditure clashes with the country’s long-established ambition to remain a leading hub for innovation, scientific research, and advanced manufacturing. Han Steutel, President of the vfa, cautions that although Germany continues to benefit from world-class scientific…
See our Cookie Privacy Policy Here
